IGF-2 LR3Understand the science
Why Binding Proteins Change the Interpretation of Long R3 IGF-I Experiments
1 numbered sourceSource years 1992
A peptide is a short chain of amino acids linked by peptide bonds. In larger growth factors, the chain can interact with receptors as well as proteins that bind the growth factor before it reaches a receptor. Long R3 IGF-I is a defined IGF-I analog. It is distinct from native IGF-II, and its published activity does not identify the catalog material named IGF-2 LR3. The older original comparison is cited because it directly asks how binding proteins influenced the analog's effects. [1]
Francis and colleagues compared several IGF-I analogs with native IGF-I in laboratory cell systems. They observed that the relative effects of the analogs varied among the systems studied. Long R3 IGF-I showed stronger responses than native IGF-I in some cells where IGF-binding proteins were present. In a different cell system without detectable secretion of those binding proteins, the result went the other way. These comparisons helped the researchers separate activity at a receptor from changes in the amount of growth factor that was available to reach it. [1]
This matters because saying that a substance is more potent leaves a question unanswered: more potent at doing what, and under what conditions? A response in one cell system can reflect receptor binding, binding to other proteins or changes in the measurement itself. The relative result cannot automatically be carried over to a different system, much less to a different molecule. [1]
A reliable evidence summary therefore keeps the names intact: the paper compared a defined IGF-I analog and native IGF-I. It does not test an IGF-II analog under the supplied label. The distinction is useful for reading claims about research potency and for spotting comparisons where the identity has been assumed. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
- 1.Francis GL et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology (1992-06). (opens in a new tab)
pubmed.ncbi.nlm.nih.gov↩ Back to text
